Related Experiment Videos
Parameters predicting response to alpha-interferon treatment in chronic hepatitis C
Hepato-Gastroenterology
|March 1, 1997
Summary
Predicting response to alpha-interferon for chronic hepatitis C is crucial. Factors like absence of cirrhosis and specific hepatitis C virus (HCV) genotypes influence treatment outcomes.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis C (HCV) treatment with alpha-interferon has limited sustained response rates (25%).
- Identifying predictors of treatment response is essential for optimizing patient outcomes.
Purpose of the Study:
- To identify pretreatment factors that predict sustained response to alpha-interferon therapy in chronic hepatitis C patients.
Main Methods:
- Forty-nine chronic hepatitis C patients received standard alpha-interferon therapy.
- Demographic, biochemical, immunological parameters, and HCV genotypes were assessed pre-treatment.
Main Results:
- Sustained response rate was 24.5%.
- Hepatitis C virus (HCV) genotype 1b was associated with poorer outcomes compared to other genotypes.
- Absence of cirrhosis, non-1b HCV genotype, higher ALT levels, and increased CD8+ liver infiltrates predicted response.
Conclusions:
- Treatment response is influenced by viral factors (HCV genotype) and host immune response (CD8+ infiltrates).
- Pretreatment factors can predict the efficacy of alpha-interferon therapy for chronic hepatitis C.